| The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. | |
| | |
MedLine Citation:
|
PMID: 10772084 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Antiretroviral therapy (ART) and Caesarean section (CS) delivery significantly reduce the risk of vertically transmitted HIV infection. Attention must focus on determining the optimal management strategy for HIV-positive pregnancies. Guidelines must reflect not only the activity and tolerability of combination ART in pregnancy for mother and infant and the potential short and long-term infant toxicity, but also whether surgical delivery can confer an added benefit if combination ART had reduced plasma viraemia to undetectable levels. To aid the development of management strategies for the Republic of Ireland, a retrospective detailed review of all HIV-positive pregnancies since the introduction of combination ART was undertaken. Since 1997 there have been 25 deliveries to 24 women. Combination ART reduced plasma viraemia to undetectable levels in 76% mothers at delivery. The CS rate was 28% and no unanticipated infant toxicity was encountered. To date no infant has proven infected. Three infants have seroreverted and 24 of 26 infants have had at least 2 negative HIV ribonucleic acid (RNA) and polymerase chain reaction (PCR) tests. Two infants are less than one month old. In this study, the CS rate of 28% is below that reported from many centres yet no vertical transmission was found. Given the efficacy of ART in reducing plasma viraemia, the additional benefit of CS for these women is questionable. |
| | |
Authors:
|
S M Clarke; F Mulcahy; C M Healy; S Condon; K M Butler |
Related Documents
:
|
23468874 - 454 pyrosequencing analysis on faecal samples from a randomized dbpc trial of colicky i... 21478704 - Visual development in infants: physiological and pathological mechanisms. 21511414 - Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes ... 20588184 - Considerations in using us-based laboratory toxicity tables to evaluate laboratory toxi... 21838884 - The taiwan birth panel study: a prospective cohort study for environmentally- related c... 20841124 - Mothers' and physicians' sources of information on infant feeding: relation to nutritio... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of STD & AIDS Volume: 11 ISSN: 0956-4624 ISO Abbreviation: Int J STD AIDS Publication Date: 2000 Apr |
Date Detail:
|
Created Date: 2000-06-27 Completed Date: 2000-06-27 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9007917 Medline TA: Int J STD AIDS Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 220-3 Citation Subset: IM; X |
Affiliation:
|
Department of Genito-Urinary Medicine, St James' Hospital, Dublin, Ireland. gum@stjames.ie |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Anti-HIV Agents / adverse effects, therapeutic use* Drug Therapy, Combination Female HIV Infections / drug therapy*, immunology, virology HIV Protease Inhibitors / adverse effects, therapeutic use* HIV-1* / genetics Humans Indinavir / adverse effects, therapeutic use Infant Lamivudine / adverse effects, therapeutic use* Male Nelfinavir / adverse effects, therapeutic use Nevirapine / adverse effects, therapeutic use Pregnancy Pregnancy Outcome Reverse Transcriptase Inhibitors / adverse effects, therapeutic use* Ritonavir / adverse effects, therapeutic use Saquinavir / adverse effects, therapeutic use Treatment Outcome Zidovudine / adverse effects, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/HIV Protease Inhibitors; 0/Reverse Transcriptase Inhibitors; 0/Ritonavir; 127779-20-8/Saquinavir; 129618-40-2/Nevirapine; 134678-17-4/Lamivudine; 150378-17-9/Indinavir; 159989-64-7/Nelfinavir; 30516-87-1/Zidovudine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Cana...
Next Document: Significance of laboratory findings for the diagnosis of neurosyphilis.